secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0000947871-23-000994
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS CFO Shawn Guertin takes leave; Tom Cowhey named interim CFO; Mike Pykosz interim Health Svcs Pres
--------------------------------------------------------------------------------

- Guertin's leave effective immediately for unforeseen family medical reasons; Cowhey (SVP Corporate Finance) appointed interim CFO.
- Mike Pykosz, CEO of Oak Street Health, named interim President of Health Services, assuming Guertin's dual role.
- FY2023 GAAP EPS guidance reaffirmed at $6.53-$6.75; Adjusted EPS reaffirmed at $8.50-$8.70.
- Q3 earnings call remains Nov 1, 2023; Investor Day remains Dec 5, 2023, as previously scheduled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/ss2584510_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-23-000994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer